About bulvirtide
Antiviral entry inhibitor
Used for
- Chronic hepatitis D infection in people with compensated liver disease
Usual adult dose
Injection under the skin once daily. Treatment duration depends on response and may be long-term.
Usual dose in children
Children aged 3 years or older weighing at least 10 kg: weight-based injection under the skin once daily.
Common side effects
- Raised bile acid levels in blood
- Itching
- Headache
- Injection-site redness, swelling, or pain
Important warnings
- Stopping treatment can cause severe hepatitis flare-ups.
- Liver function and viral levels require regular monitoring.
- Serious allergic reactions can occur.
- Safety in advanced, decompensated liver disease is not established.
Pregnancy
Pregnancy data are limited. Use during pregnancy is generally avoided as a precaution.
Breastfeeding
Whether it enters breast milk is unknown. A decision is needed between breastfeeding and treatment, considering benefits and risks.
Interactions
- Cyclosporine
- Ezetimibe
- Ritonavir
- Certain statins, including rosuvastatin
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.